O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.17B
AUM Growth
+$193M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
120
New
Increased
Reduced
Closed

Top Buys

1
+$52.4M
2
+$48.2M
3
+$38.6M
4
ASND icon
Ascendis Pharma
ASND
+$29.4M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$28.9M

Top Sells

1
+$105M
2
+$93.6M
3
+$81.8M
4
BSX icon
Boston Scientific
BSX
+$39.8M
5
CYTK icon
Cytokinetics
CYTK
+$35.6M

Sector Composition

1 Healthcare 99.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRVS icon
26
Corvus Pharmaceuticals
CRVS
$1.53B
$52.8M 1.27%
7,165,006
APLS icon
27
Apellis Pharmaceuticals
APLS
$2.68B
$52.6M 1.26%
2,323,368
+841,068
DHR icon
28
Danaher
DHR
$149B
$52.2M 1.25%
+263,100
NBIX icon
29
Neurocrine Biosciences
NBIX
$13.3B
$49.6M 1.19%
353,640
-84,900
UTHR icon
30
United Therapeutics
UTHR
$21.7B
$48.2M 1.16%
+114,900
CI icon
31
Cigna
CI
$76.4B
$46.9M 1.13%
+162,800
CRNX icon
32
Crinetics Pharmaceuticals
CRNX
$4.21B
$45.8M 1.1%
1,099,000
-50,000
ORIC icon
33
Oric Pharmaceuticals
ORIC
$1.31B
$43.7M 1.05%
3,641,756
+2,742,475
JANX icon
34
Janux Therapeutics
JANX
$819M
$43.2M 1.04%
1,766,100
+555,800
ROIV icon
35
Roivant Sciences
ROIV
$20.7B
$41.1M 0.99%
2,714,798
-64,629
ASND icon
36
Ascendis Pharma
ASND
$14.3B
$38.2M 0.92%
191,905
+157,505
SIBN icon
37
SI-BONE Inc
SIBN
$673M
$38M 0.91%
2,578,979
SCPH
38
DELISTED
scPharmaceuticals
SCPH
$34.4M 0.82%
6,059,528
ABVX
39
Abivax
ABVX
$9.59B
$32.3M 0.77%
+380,000
GPCR icon
40
Structure Therapeutics
GPCR
$4.45B
$31.9M 0.77%
1,139,300
-60,000
TRVI icon
41
Trevi Therapeutics
TRVI
$1.53B
$30.3M 0.73%
3,308,400
ITGR icon
42
Integer Holdings
ITGR
$2.98B
$30M 0.72%
290,000
-143,400
DYN icon
43
Dyne Therapeutics
DYN
$2.57B
$29.3M 0.7%
2,314,184
+1,282,784
RAPT icon
44
RAPT Therapeutics
RAPT
$1.68B
$28M 0.67%
1,086,618
-555,288
CTMX icon
45
CytomX Therapeutics
CTMX
$910M
$27M 0.65%
8,461,500
NPCE icon
46
Neuropace
NPCE
$486M
$27M 0.65%
2,614,184
QURE icon
47
uniQure
QURE
$974M
$26.8M 0.64%
+458,500
EYPT icon
48
EyePoint Inc
EYPT
$1.45B
$25.6M 0.61%
+1,796,000
AKRO
49
DELISTED
Akero Therapeutics
AKRO
$25M 0.6%
526,200
+314,900
ADCT icon
50
ADC Therapeutics
ADCT
$508M
$23.6M 0.57%
5,907,351
1
2
3 4 5